Advent Life Sciences Fund I Lp
Advent Life Sciences Fund I Lp: address, phone, fax, email, web site, schedule
Advent Life Sciences Fund I Lp
Locality: London
Address: 158-160 NORTH GOWER STREET London NW1 2ND
Phone: +44-1285 6894989
Fax: +44-1285 6894989
E-mail:
Web site:
Director / owner / responsible person Advent Life Sciences Fund I Lp: n\a
Schedule:
Find error in description or want add more information on you company? - Contact me!
Advent Life Sciences Fund I Lp credits: register number, status, company type, incorporation date
Register number:
Company type: Limited Partnership
Status: Active
Incorporation date: 15-07-2009
Get full report form global database UK for Advent Life Sciences Fund I Lp
Service Advent Life Sciences Fund I Lp: NONE SUPPLIED, None Supplied, None Supplied
Job on Advent Life Sciences Fund I Lp vacancies, practice, working, traineeship, career
In Advent Life Sciences Fund I Lp open follow vacancies:
Electrician. 1800 GBP.
Tester. 2600 GBP.
Responds for Advent Life Sciences Fund I Lp on facebook
Responds about Advent Life Sciences Fund I Lp. Add respond for Advent Life Sciences Fund I Lp in social networks
Advent Life Sciences Fund I Lp on map and Google map and street view
Also view related and similar companies and organisation this bisness category, as Advent Life Sciences Fund I Lp: Sports Partnership Herefordshire and Worcestershire | Jake Vernum Limited | Estrans Developments (Severn Beach) Limited | Santoro Retail Limited | Phone Depot Old Hill Ltd
Advent Life Sciences Fund I Lp is a Limited Partnership. Company number assigned by Companies House is LP013554. The company was incorporated on Wednesday 15th July 2009, so the company age is 6 years 11 months 10 days. The company registration status is Active. We have no data about company Standard Industrial Classification (SIC). Advent Life Sciences Fund I Lp register address is 158-160 NORTH GOWER STREET, London (area code: NW1 2ND). The company changed its name 2 times. On Friday 20th May 2011 the name changed to Advent Ventures Life Sciences Fund.